Xylitol Gum for Promoting Smoking Cessation

November 16, 2025 updated by: Prof. Wang Man-Ping, The University of Hong Kong

The Effectiveness of Chewing Gum for Reducing Cigarette Consumption and Promoting Smoking Cessation: A Pilot Randomized Controlled Trial

The goal of this clinical trial is to learn if 4-week xylitol gum intervention works to promote smoking cessation in daily smokers. It will also learn about the feasibility and acceptability of using xylitol gum. The main questions it aims to answer are:

(1)Does xylitol gum help to reduce cigarette consumption and promote smoking cessation?

Researchers will compare 4-week xylitol gum intervention to the brief advice to see if xylitol gum works to promote smoking cessation.

Participants in the intervention group will receive a 3-month behavioral intervention comprising a 4-week xylitol gum aligned with 12 weeks of instant reminder message support.

Study Overview

Detailed Description

This study aims to evaluate the feasibility, acceptability, and preliminary effectiveness of a proactive smoking cessation intervention using xylitol chewing gum. Eligible participants will be Hong Kong residents aged ≥18 years who (1) have smoked at least one cigarette per day in the past 3 months; (2) can communicate in Cantonese (including reading Chinese); (3) express an intention to quit or reduce smoking; (4) are able to use instant messaging tools (e.g., WhatsApp); and (5) regularly chew gum or are willing to use chewing gum for smoking reduction.

A total of 134 participants will be recruited from community settings, including public housing estates across Hong Kong's 18 districts, community and university smoking hotspots, referrals from other smoking cessation programmes, and social media promotions (Facebook and Instagram). The study will adopt a hybrid type I effectiveness-implementation design. Participants will be followed up at 1, 3, and 6 months post-enrolment via telephone, following CONSORT guidelines, to assess cigarette reduction and cessation outcomes.

All participants will receive brief smoking cessation advice at baseline using the AWARD model (Ask/Assess, Warn, Advise, Refer, and Do-it-again), accompanied by a health warning leaflet and a smoking cessation information booklet.

Interventions are as follows:

Chewing gum group (intervention): Participants will receive 4 packs of xylitol gum at baseline and up to 24 packs throughout the 12-week intervention. Approximately 24 reminder messages (two per week), developed based on the Love and Care Approach framework, will be delivered via instant messaging to reinforce motivation and adherence.

Unassisted quitting group (control): Participants will receive brief advice only at baseline.

To explore user experience and acceptability, semi-structured qualitative interviews will be conducted with 20 intervention-group participants to understand their perceptions and experiences with xylitol gum use.

The primary outcome is biochemically validated smoking abstinence at 6 months, defined as exhaled carbon monoxide <4 ppm and salivary cotinine <30 ng/mL.

Study Type

Interventional

Enrollment (Estimated)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Man Ping Wang, PhD
  • Phone Number: +852 3917 6636
  • Email: mpwang@hku.hk

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Residents of Hong Kong aged 18 or above who smoke at least 1 cigarette per day over the past 3 months
  • Have the habit of chewing gum or are willing to use chewing gum
  • Can communicate in Cantonese (including reading Chinese)
  • Express an intention to quit or reduce smoking
  • Capable of using instant messaging tools (e.g., WhatsApp, WeChat) for communication

Exclusion Criteria:

  • Have communication barriers (either physical or cognitive)
  • Currently participating in other smoking cessation programs or services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Participants assigned to the intervention group will receive a 3-month behavioral intervention comprising a 4-week xylitol gum aligned with 12 weeks of instant reminder message support.
Brief smoking cessation advice guided by the validated AWARD model (Assess, Warning, Advice, Refer, and Do-it-again).
The warning leaflet contains pictorial depictions of the adverse health effects of smoking.
The self-help smoking cessation booklet includes commonly used smoking cessation strategies.
Participants in the intervention group will receive 4 packs of xylitol gum (approximately US $2 per pack) at baseline and will be encouraged to use it when they experience cravings.
The instructional leaflet includes the potential benefits of xylitol gum for smoking cessation, recommended timing and dosage for use, and appropriate disposal of used gum.
Approximately 24 reminder messages (two per week), developed based on the Love and Care Approach framework, will be delivered over the 12-week period to reinforce motivation and adherence.
Active Comparator: Control group
Participants in the control group will receive brief SC advice and a SC information booklet at baseline, which had been routinely used in our previous trials.
Brief smoking cessation advice guided by the validated AWARD model (Assess, Warning, Advice, Refer, and Do-it-again).
The warning leaflet contains pictorial depictions of the adverse health effects of smoking.
The self-help smoking cessation booklet includes commonly used smoking cessation strategies.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically validated smoking abstinence
Time Frame: 6-month follow-up
Verified by exhaled carbon monoxide <4 ppm and salivary cotinine <30 ng/ml
6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biochemically validated smoking abstinence
Time Frame: 3-month follow-up
Verified by exhaled carbon monoxide <4 ppm and salivary cotinine <30 ng/ml
3-month follow-up
Self-report 7-day point-prevalence abstinence
Time Frame: 1-, 3-, and 6-months follow-ups
By asking a question, "Have you smoked (even a puff) during the past 7 days?"
1-, 3-, and 6-months follow-ups
Smoking reduction
Time Frame: 1-, 3-, and 6-months follow-ups
Defined by a reduction of≥50% in daily cigarette consumption compared with baseline.
1-, 3-, and 6-months follow-ups
Quit attempt
Time Frame: 1-, 3-, and 6-months follow-ups
By asking a question, "Have you attempted to stop smoking completely for at least 24 hours in the past 7 days?"
1-, 3-, and 6-months follow-ups

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of pieces of xylitol gum used
Time Frame: 1- and 3-month follow-ups
Total daily count used during the intervention period
1- and 3-month follow-ups
Frequency of using xylitol gum
Time Frame: 1- and 3-month follow-ups
Average number of chewing episodes per day.
1- and 3-month follow-ups
Duration of use
Time Frame: 1- and 3-month follow-ups
Average time spent chewing each piece.
1- and 3-month follow-ups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Man Ping Wang, PhD, The University of Hong Kong

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 24, 2025

Primary Completion (Estimated)

February 28, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

November 16, 2025

First Submitted That Met QC Criteria

November 16, 2025

First Posted (Actual)

November 21, 2025

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 16, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Chew 2 quit

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Brief smoking cessation advice

Subscribe